Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scorpion venom is a complex biological mixture composed of various proteins, peptides, and small molecules, primarily designed for prey immobilization and defense (StatPearls, 2023). The most pharmacologically significant components are neurotoxins that selectively bind to and modulate the activity of voltage-gated ion channels, particularly sodium, potassium, calcium, and chloride channels (Toxins, 2021). This interaction leads to excessive release of neurotransmitters, resulting in a 'sympathetic storm' or 'cholinergic crisis' depending on the species (NIH, 2022). In a clinical context, the venom is the target of antivenom therapies, such as Centruroides Immune F(ab')2, which utilize purified antibody fragments to sequester toxins from the systemic circulation (FDA, 2011). Beyond its toxicity, scorpion venom serves as a rich source of bioactive molecules for drug discovery, with specific toxins like chlorotoxin being investigated for their potential in treating glioma and other cancers (PubMed, 2020). The venom's complexity poses a challenge for treatment, as different species require specific antivenoms to effectively neutralize the unique toxin profiles present (WHO, 2021).
Antivenoms (e.g., Anascorp) consist of venom-specific F(ab')2 antibody fragments that bind and neutralize venom toxins, preventing their interaction with voltage-gated ion channels and facilitating their elimination (FDA, 2011; StatPearls, 2023).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scorpion venom.